General | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Comparison | ||||||||||||||||||||||||||||
|
Northwest Biotherapeutics: Q1 Earnings Snapshot | news.google.com • |
Northwest Bio: Another Small Filing Delay | seekingalpha.com • |
Northwest Bio: Is There Ever Going To Be A Right Time? | seekingalpha.com • |
Biotech Firm Claims Citadel, Other Market Makers Manipulated Stock Price | 247wallst.com • |
NWBO Stock Alert: Northwest Bio Slams Citadel Securities in New Lawsuit | investorplace.com • |
Northwest Biotherapeutics: Data Is Done, Just Wait For Approval | seekingalpha.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-05-10 | 2024-03 | 0 | -0.02 | N/A | N/A |
2024-03-05 | 2023-12 | 0 | -0.02 | N/A | N/A |
2023-11-09 | 2023-09 | 0 | -0.02 | N/A | N/A |
2023-08-09 | 2023-06 | 0 | -0.01 | N/A | N/A |
2023-05-10 | 2023-03 | 0 | -0.01 | N/A | N/A |
2023-02-28 | 2022-12 | 0 | -0.03 | N/A | N/A |
Date | Firm | Action | From | To |
---|---|---|---|---|
2014-03-11 | Oppenheimer | Downgrade | Outperform | Perform |
2013-10-15 | Oppenheimer | Upgrade | Outperform | |
2013-09-18 | Summer Street Research | Upgrade | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2015-06-29 | COGNATE BIOSERVICES, INC. | Beneficial Owner (10% or more) | 18.46M | Sale |
2015-11-04 | WOODFORD INVESTMENT MANAGEMENT LLP | Beneficial Owner (10% or more) | 18.32M | Ownership Statement |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2016-09-29 | Woodford Investment Management LLP | 25.92M | 13.99M | 20.79% |
2016-09-29 | Credit Suisse/ | 1.90M | 1.03M | 1.52% |
2016-09-29 | Vanguard Group, Inc. (The) | 1.38M | 744.63K | 1.11% |
2016-09-29 | Goldman Sachs Group, Inc. | 994.70K | 537.14K | 0.80% |
2016-09-29 | BlackRock Institutional Trust Company, N.A. | 717.91K | 387.67K | 0.58% |
2016-09-29 | Millennium Management LLC | 357.41K | 193.00K | 0.29% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2016-06-29 | Vanguard Total Stock Market Index Fund | 968.77K | 561.89K | 0.78% |
2016-06-29 | Vanguard Extended Market Index Fund | 546.67K | 317.07K | 0.44% |
2016-08-30 | Fidelity Extended Market Index Fund | 158.54K | 53.90K | 0.13% |
2016-08-30 | Fidelity Total Market Index Fund | 60.54K | 20.58K | 0.05% |
2016-06-29 | Vanguard Institutional Index-Inst Total Stock Market Ind | 33.90K | 19.66K | 0.03% |
2016-08-30 | Fidelity NASDAQ Composite Index Fund | 27.00K | 9.18K | 0.02% |
Split | Date |
---|---|
0.0625 : 1 | 2012-09-26 |
0.06667 : 1 | 2007-06-28 |
Tell someone with GBM they can’t have it
Refer to article on the net “Timing and completeness of trial results posted on clinical trials.gov.”
We are currently at the average time for clinical results at 19 months
TJ is just a lonely guy with ADHD and needs attention. Say a prayer for him god bless him. He’s like a child in a high chair drooling trying to cut his teeth.
I’d say with the volume it hits $4-7
It’s not my first rodeo.
I’ll take my chances name.
It’s a subconscious cry for help and I understand so email or test me and I’ll point you in the right direction and AF too because it’s hard for a man to fall from Grace
I’m just curious what’s it like to be totally insignificant brother? Does it hurt? I guess people just don’t understand you but you mean we’ll I’m sure.
But I get it anything beats nothing. God bless you your trying
Your getting particularly lame TJ you better step up your game I think your becoming a the village idiot
I think you have diarrhea of the brain and mouth and you should enter a trial for that indication.
I’m confused TJ. Why would Merck be interested in combination DCVax and Keytruda trial after having The Godfather of Keytruda on board there? I really want an intelligent explanation if as you say DCVax failed️
The price continues to drop simply because of of dogshit weak hands. The key is and always been volume, just look at it 4-500k shares not even $500k. ️give me a break. You will see volume of 5-600 million on news dummy.
I say Merck grabs them. It’s a marriage that breathes new life into Keytruda much like Amgens repurposed Neupogen
The volume is simply trading even at 3 million shares its only 2.4 million comn guys this stock is waiting for news and the 100’s of millions will appear.
I’m wondering but confused why do people who believe that the therapy is a failure bother to post here
Hold 600k shares
Bought 50k more
Added 50k shares